Clinical Trials Browser

Phase 2 × Lymphangioleiomyomatosis × Everolimus × Clear all

NCT01059318 2020-11-19

A Study to Determine the Safety and Effectiveness of RAD001 (Everolimus) in Patients With Lymphangioleiomyomatosis

Phase 2 Completed

24 enrolled 13 charts

Lymphangioleiomyomatosis